<DOC>
	<DOCNO>NCT00589537</DOCNO>
	<brief_summary>RATIONALE : Imaging procedure , MRI CT scan , may find recurrent cancer . It yet know MRI CT scan schedule effective finding recurrent cancer . PURPOSE : This randomized phase III trial compare four different MRI CT scan schedule patient stage I seminoma testicle .</brief_summary>
	<brief_title>Magnetic Resonance Imaging Computed Tomography Patients With Stage I Seminoma Testicle</brief_title>
	<detailed_description>OBJECTIVES : - To assess whether reduce compute tomography ( CT ) schedule magnetic resonance imaging ( MRI ) could use safe effective alternative standard CT-based surveillance management patient stage I seminoma testis . OUTLINE : This multicenter study . Patients randomize 1 4 surveillance arm . - Arm I : Patients undergo compute tomography ( CT ) scan abdomen/retroperitoneum* 6 , 12 , 18 , 24 , 36 , 48 , 60 month absence disease progression . - Arm II : Patients undergo CT scan abdomen/retroperitoneum* 6 , 18 , 36 month absence disease progression . - Arm III : Patients undergo magnetic resonance imaging ( MRI ) abdomen/retroperitoneum* 6 , 12 , 18 , 24 , 36 , 48 , 60 month absence disease progression . - Arm IV : Patients undergo MRI abdomen/retroperitoneum* 6 , 18 , 36 month absence disease progression . NOTE : *Patients history ipsilateral inguino-scrotal surgery also undergo image pelvis . Patients complete questionnaire baseline periodically study assess health-related quality life ; utilization cost healthcare service ( include cost CT- MRI-based surveillance management recurrence ) ; acceptability allocate scan schedule . Patients follow every 3 month 2 year , every 4 month 1 year , every 6 month 3 year .</detailed_description>
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<mesh_term>Seminoma</mesh_term>
	<mesh_term>Testicular Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm seminoma testis Stage I disease , determine clinical examination CT scan chest , abdomen , pelvis No evidence nonseminoma germ cell tumor element Has undergone orchidectomy within past 8 week Normal serum alphafetoprotein preorchidectomy study randomization Normal serum beta human chorionic gonadotrophin study randomization ( may elevate preorchidectomy ) Not plan undergo adjuvant therapy PATIENT CHARACTERISTICS : Able attend regular surveillance No malignancy within past 10 year expect successfully treat nonmelanoma skin cancer No contraindication MRI ( i.e. , ferrous metal implant type , cardiac pacemaker defibrillator , history injury metal fragment ) PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>Male</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>testicular seminoma</keyword>
	<keyword>stage I malignant testicular germ cell tumor</keyword>
</DOC>